#United States #Houston #Avance Biosciences #Potency Assay Center #Cell-Based Assays

Avance Biosciences Launches a New Center in Houston

Avance Biosciences has officially announced the opening of its Potency and Cell-Based Assay Center of Excellence in Houston. This new facility is strategically designed to elevate the company's capabilities in potency and functional cell-based assays while adhering to Good Manufacturing Practice (GMP) standards. The center aims to support clients in the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.

The decision to establish the new Center was driven by an increased demand from customers for high-quality custom potency assays. The facility is well-equipped with advanced instruments and staffed by a team of skilled cell biologists and assay development experts. Key offerings at the Center include:

• - Custom potency assay development tailored specifically to various product mechanisms of action.
• - Fit-for-purpose potency assay qualification and validation in conjunction with ICH Q2(R2) regulations.
• - GMP-compliant potency assay sample testing catering to both clinical and commercial programs.

Enhancing Client Experience

Cal Froberg, Senior Vice President of Sales and Marketing at Avance Biosciences, shared, "Our clients consistently appreciate the scientific expertise and customer-oriented approach our teams infuse into their potency assay projects. By centralizing our functions in a specialized Center, we can provide GMP-compliant potency assay services with improved speed, consistency, and operational efficiency."

The establishment of this facility strengthens Avance Biosciences' long-standing reputation as a reliable partner within the regulated biologics and cell-based assay sector. The Center is poised to deliver precise, reproducible, and scientifically robust potency data to support the next wave of therapeutic modalities confidently.

Xuening Huang, PhD, the CEO of Avance Biosciences, remarked upon the launch, stating, "We've unified an outstanding team and expanded our capabilities to provide complex, custom assays for our growing clientele. This initiative signifies Avance's ongoing commitment to offering top-tier analytical and bioanalytical solutions for advanced therapeutic developments."

With extensive experience across diverse modalities and platforms, including lipid nanoparticles, monoclonal antibodies, vaccines, viral vectors, and engineered cell therapies, the potency assay team is prepared to respond promptly to market needs. Centralizing these efforts at the new Center allows for faster turnaround, standardized workflows, and an enhanced customer experience.

A Commitment to Innovation

Avance Biosciences has an impressive track record in providing GLP-, GMP-, and CLIA-compliant testing services that support drug development, biologics creation, and advancements in cell and gene therapies. Their profound knowledge in molecular biology, sequencing, cell-based assays, and bioanalytical testing helps advance projects from discovery to market launch.

For those interested in the significance of potency assays and their role in evaluating the effectiveness of complex therapeutics, the company also provides a technical note titled, "Successful Development of Cell-Based Potency Assays."

To learn more about Avance Biosciences and its new Potency and Cell-Based Assay Center, visit www.avancebio.com/potency or reach out via email at [email protected].